Abstract
Secretin infusion in man causes an increase in renal blood flow. The aim of the present study was to assess further the cardiovascular effects of the hormone. Secretin was infused at a rate of 2 CU/kg X h to patients with angina pectoris and normal left ventricular function. Cardiac output increased by an average of 20%, the stroke volume increased and the total systemic resistance decreased. Systemic arterial pressure, heart rate and pulmonary capillary wedge pressure were unaltered. The results are compatible with a combined inotropic and vasodilating effect of the hormone. It is concluded that secretin may have potential merits in the treatment of acute left ventricular failure.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Scandinavian Journal of Clinical & Laboratory Investigation
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
